EBSA conference 2024

Antwerp, Belgium

14-15 May 2024 - preconference courses

In Antwerp we will have 9 courses for you.
You can already check them out now and book your seat at Super Early Bird prices before February 1st.

• A - Biological Risk Assessment – from paper to practice
• B - Auditing: a comprehensive and practical introduction
• C - Field Biosafety perspectives on One Health: From sampling multiple species to working in a Mobile Lab
• D - Mastering BSL-3 Laboratory Operations Throughout Its Lifecycle: Overcoming Challenges at Every Stage
• E - Basics in Biosecurity
• F - How to contain insects: challenges to be overcome when working with invasive species vectoring diseases. EXACT DATE TO BE CONFIRMED
• G - Safety equipment in contained laboratories: from the biosafety cabinet to individual protection, a practical approach
• H - Key challenges to assessing training & competency
• I - Synthetic Biology; from Mainstream to Counterculture – Theory, Practice & Safety

16-17 May 2024 - Conference

Cutting egde of biosafety

• Session 1 (Novel) Approaches in BioRisk Assessments
  The 4th edition of the WHO LBM recommends a greater reliance on risk assessment in biosafety based on evidence. In this session examples of novel approaches to risk assessment will be described for a range of scientific activities
  
• Session 3 Implementing Biosecurity
  How are organisations conducting R&D in bioscience addressing Dual Use and Biosecurity in their management systems.A lot of policies have been published by funders and governments about the needs to actively manage potential Dual Use issues or Dual Use Research of Concern (DURC). How are organisations setting up their DURC/Dual Use Oversight Programs? EBSA is inviting practitioners to share their experience in the field of managing dual use in their organisations.
• Session 4 Evidence-based Biosafety / Applied Biosafety
  In some cases, biorisk management is based on outdated research, risk aversion, or ad hoc protocols that lack a sufficient evidence base to support it. There is a need for evidence-based laboratory management practices, guidance and regulations to ensure that biorisk management is both proportionate to the risks and effective to lower the risk to acceptable levels. In addition, it also helps in raising the public's confidence in the many laboratory activities carried out throughout the globe in labs and other research institutes.
• Session 5 New Technological Advances & Biosafety aspects
  In this session we will focus on biosafety aspects of New Technological Advances. We are inviting abstracts ranging from new genomic techniques, gene drives, bioremediation, or soil microbe mining, over therapy- and vaccine development for emerging diseases, to the development of peptide bioregulators or the use of innovative pieces of equipment for managing samples fully automatically, just to name a few. Contributions should address those biorisk aspects that go beyond the typical handling of biotechnology or pathogenic materials as well as the specific measures put in place to tackle them.

We are still looking out for your contributions!

• offered oral presentations
  We have 30 minutes slots available in all sessions.
  
  
• posters, presenting your research results.
  After this years success we will repeat the "Pitch" session at the coference! A selection of authors will be invited to give a 10-minute presentation of their poster during the main conference program. The best combination of presentation and poster will be awarded the special poster prize.

Note: 22 January 2024 Submission deadline for oral presentation and 29 February 2024 for posters

You are a company providing services or products to biosafety professionals? You want to sponsor the conference or be present at the exhibition? Different options are available, just check out our sponsor and exhibitor page!